Correlation Between Silver Spike and Collegium Pharmaceutical
Can any of the company-specific risk be diversified away by investing in both Silver Spike and Collegium Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Silver Spike and Collegium Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Silver Spike Investment and Collegium Pharmaceutical, you can compare the effects of market volatilities on Silver Spike and Collegium Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Silver Spike with a short position of Collegium Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Silver Spike and Collegium Pharmaceutical.
Diversification Opportunities for Silver Spike and Collegium Pharmaceutical
0.5 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Silver and Collegium is 0.5. Overlapping area represents the amount of risk that can be diversified away by holding Silver Spike Investment and Collegium Pharmaceutical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Collegium Pharmaceutical and Silver Spike is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Silver Spike Investment are associated (or correlated) with Collegium Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Collegium Pharmaceutical has no effect on the direction of Silver Spike i.e., Silver Spike and Collegium Pharmaceutical go up and down completely randomly.
Pair Corralation between Silver Spike and Collegium Pharmaceutical
Given the investment horizon of 90 days Silver Spike Investment is expected to generate 0.82 times more return on investment than Collegium Pharmaceutical. However, Silver Spike Investment is 1.22 times less risky than Collegium Pharmaceutical. It trades about 0.35 of its potential returns per unit of risk. Collegium Pharmaceutical is currently generating about -0.11 per unit of risk. If you would invest 1,000.00 in Silver Spike Investment on February 4, 2024 and sell it today you would earn a total of 117.00 from holding Silver Spike Investment or generate 11.7% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Silver Spike Investment vs. Collegium Pharmaceutical
Performance |
Timeline |
Silver Spike Investment |
Collegium Pharmaceutical |
Silver Spike and Collegium Pharmaceutical Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Silver Spike and Collegium Pharmaceutical
The main advantage of trading using opposite Silver Spike and Collegium Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Silver Spike position performs unexpectedly, Collegium Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Collegium Pharmaceutical will offset losses from the drop in Collegium Pharmaceutical's long position.Silver Spike vs. Entourage Health Corp | Silver Spike vs. Avicanna | Silver Spike vs. Benchmark Botanics | Silver Spike vs. Speakeasy Cannabis Club |
Collegium Pharmaceutical vs. Incyte | Collegium Pharmaceutical vs. Sarepta Therapeutics | Collegium Pharmaceutical vs. ACADIA Pharmaceuticals | Collegium Pharmaceutical vs. Viking Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Other Complementary Tools
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |